*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C321 - Malignant neoplasm of supraglottis - as a primary diagnosis code | C321 - Malignant neoplasm of supraglottis - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 8.7 | |
| Readmission Rate (%) | 34.49 | |
| Unplanned Readmission Rate (%) | 15.67 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 011: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 012: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 146: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 013: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 147: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 5,676 | ||||
| Total Hospitalizations with ICD C321 - Malignant neoplasm of supraglottis | 603 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD C321 - Malignant neoplasm of supraglottis in DRG | 26.38 | ||||
| Avg LOS at DRG | 13.29 | ||||
| Avg LOS with ICD C321 - Malignant neoplasm of supraglottis | 13.42 | ||||
| Readmission Rate at DRG | 39.33 | ||||
| Readmission Rate with ICD C321 - Malignant neoplasm of supraglottis | 43.16 | ||||
| Unplanned Readmission Rate at DRG | 14.94 | ||||
| Unplanned Readmission Rate with ICD C321 - Malignant neoplasm of supraglottis | 18.65 | ||||
| Total Medicare payments at DRG | $228,782,019 | ||||
| Total Medicare payments with ICD C321 - Malignant neoplasm of supraglottis | $23,115,835 | ||||
| Total Medicare payment per Day at DRG | $3,033 | ||||
| Total Medicare payment per Day with ICD C321 - Malignant neoplasm of supraglottis | $2,856 | ||||
| Total Medicare payment per Hospitalization at DRG | $40,307 | ||||
| Total Medicare payment per Hospitalization with ICD C321 - Malignant neoplasm of supraglottis | $38,335 | ||||
| Total Medicare Charges at DRG | $1,036,941,744 | ||||
| Total Medicare Charges with ICD C321 - Malignant neoplasm of supraglottis | $93,466,651 | ||||
| Avg Charges at DRG | $182,689 | ||||
| Avg Charges with ICD C321 - Malignant neoplasm of supraglottis | $155,003 | ||||
| Mortality Rate at DRG | 2.59 | ||||
| Mortality Rate with ICD C321 - Malignant neoplasm of supraglottis | 1.99 | ||||
| SNF Discharge Rate at DRG | 23.11 | ||||
| SNF Discharge Rate with ICD C321 - Malignant neoplasm of supraglottis | 22.22 | ||||
| Home Discharge Rate at DRG | 14.76 | ||||
| Home Discharge Rate with ICD C321 - Malignant neoplasm of supraglottis | 14.76 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 129: MAJOR HEAD AND NECK PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) OR MAJOR DEVICE | DRG 130: MAJOR HEAD AND NECK PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 148: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 004: TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITHOUT MAJOR O.R. PROCEDURE | DRG 133: OTHER EAR, NOSE, MOUTH AND THROAT O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 6,332 | ||||
| Total Hospitalizations with ICD C321 - Malignant neoplasm of supraglottis | 123 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD C321 - Malignant neoplasm of supraglottis in DRG | 5.38 | ||||
| Avg LOS at DRG | 5.14 | ||||
| Avg LOS with ICD C321 - Malignant neoplasm of supraglottis | 5.6 | ||||
| Readmission Rate at DRG | 14.35 | ||||
| Readmission Rate with ICD C321 - Malignant neoplasm of supraglottis | 25.0 | ||||
| Unplanned Readmission Rate at DRG | 7.64 | ||||
| Unplanned Readmission Rate with ICD C321 - Malignant neoplasm of supraglottis | 15.83 | ||||
| Total Medicare payments at DRG | $113,818,459 | ||||
| Total Medicare payments with ICD C321 - Malignant neoplasm of supraglottis | $2,195,312 | ||||
| Total Medicare payment per Day at DRG | $3,496 | ||||
| Total Medicare payment per Day with ICD C321 - Malignant neoplasm of supraglottis | $3,186 | ||||
| Total Medicare payment per Hospitalization at DRG | $17,975 | ||||
| Total Medicare payment per Hospitalization with ICD C321 - Malignant neoplasm of supraglottis | $17,848 | ||||
| Total Medicare Charges at DRG | $599,317,955 | ||||
| Total Medicare Charges with ICD C321 - Malignant neoplasm of supraglottis | $9,817,225 | ||||
| Avg Charges at DRG | $94,649 | ||||
| Avg Charges with ICD C321 - Malignant neoplasm of supraglottis | $79,815 | ||||
| Mortality Rate at DRG | 0.74 | ||||
| Mortality Rate with ICD C321 - Malignant neoplasm of supraglottis | NA | ||||
| SNF Discharge Rate at DRG | 9.41 | ||||
| SNF Discharge Rate with ICD C321 - Malignant neoplasm of supraglottis | 11.38 | ||||
| Home Discharge Rate at DRG | 64.53 | ||||
| Home Discharge Rate with ICD C321 - Malignant neoplasm of supraglottis | 51.22 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 134: OTHER EAR, NOSE, MOUTH AND THROAT O.R. PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 982: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|
| Total Hospitalizations at DRG | 4,008 | |||
| Total Hospitalizations with ICD C321 - Malignant neoplasm of supraglottis | 32 | |||
| DRG Share of Total Hospitalizations | 0.01 | |||
| % of Total ICD C321 - Malignant neoplasm of supraglottis in DRG | 1.4 | |||
| Avg LOS at DRG | 2.21 | |||
| Avg LOS with ICD C321 - Malignant neoplasm of supraglottis | 2.56 | |||
| Readmission Rate at DRG | 8.01 | |||
| Readmission Rate with ICD C321 - Malignant neoplasm of supraglottis | NA | |||
| Unplanned Readmission Rate at DRG | 4.82 | |||
| Unplanned Readmission Rate with ICD C321 - Malignant neoplasm of supraglottis | NA | |||
| Total Medicare payments at DRG | $26,062,342 | |||
| Total Medicare payments with ICD C321 - Malignant neoplasm of supraglottis | $198,347 | |||
| Total Medicare payment per Day at DRG | $2,941 | |||
| Total Medicare payment per Day with ICD C321 - Malignant neoplasm of supraglottis | $2,419 | |||
| Total Medicare payment per Hospitalization at DRG | $6,503 | |||
| Total Medicare payment per Hospitalization with ICD C321 - Malignant neoplasm of supraglottis | $6,198 | |||
| Total Medicare Charges at DRG | $181,374,870 | |||
| Total Medicare Charges with ICD C321 - Malignant neoplasm of supraglottis | $1,353,265 | |||
| Avg Charges at DRG | $45,253 | |||
| Avg Charges with ICD C321 - Malignant neoplasm of supraglottis | $42,290 | |||
| Mortality Rate at DRG | NA | |||
| Mortality Rate with ICD C321 - Malignant neoplasm of supraglottis | NA | |||
| SNF Discharge Rate at DRG | 2.89 | |||
| SNF Discharge Rate with ICD C321 - Malignant neoplasm of supraglottis | NA | |||
| Home Discharge Rate at DRG | 87.1 | |||
| Home Discharge Rate with ICD C321 - Malignant neoplasm of supraglottis | 81.25 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 33 |
| ARTHUR G JAMES CANCER HOSPITAL | 300 W 10TH AVE | COLUMBUS | OH | 43210 | 32 |
| RUSH UNIVERSITY MEDICAL CENTER | 1653 W CONGRESS PKWY | CHICAGO | IL | 60612 | 27 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. ISSAM N. EID | 2500 N STATE ST | JACKSON | MS | 39216 | 15 |
| Dr. WILLIAM R CARROLL | 619 19TH STREET SOUTH | BIRMINGHAM | AL | 35233 | 14 |
| Dr. EMRE VURAL | 4301 W MARKHAM ST # 783 | LITTLE ROCK | AR | 72205 | 12 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. ISSAM N. EID | 2500 N STATE ST | JACKSON | MS | 39216 | 16 |
| Dr. EMRE VURAL | 4301 W MARKHAM ST # 783 | LITTLE ROCK | AR | 72205 | 13 |
| Dr. CLARENCE T SASAKI | 800 HOWARD AVE | NEW HAVEN | CT | 06519 | 12 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 011: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 012: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 146: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 013: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 5,676 | ||||
| Total Hospitalizations with ICD C321 - Malignant neoplasm of supraglottis | 676 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD C321 - Malignant neoplasm of supraglottis in DRG | 12.08 | ||||
| Avg LOS at DRG | 13.29 | ||||
| Avg LOS with ICD C321 - Malignant neoplasm of supraglottis | 13.45 | ||||
| Readmission Rate at DRG | 39.33 | ||||
| Readmission Rate with ICD C321 - Malignant neoplasm of supraglottis | 44.13 | ||||
| Unplanned Readmission Rate at DRG | 14.94 | ||||
| Unplanned Readmission Rate with ICD C321 - Malignant neoplasm of supraglottis | 18.73 | ||||
| Total Medicare payments at DRG | $228,782,019 | ||||
| Total Medicare payments with ICD C321 - Malignant neoplasm of supraglottis | $25,719,966 | ||||
| Total Medicare payment per Day at DRG | $3,033 | ||||
| Total Medicare payment per Day with ICD C321 - Malignant neoplasm of supraglottis | $2,829 | ||||
| Total Medicare payment per Hospitalization at DRG | $40,307 | ||||
| Total Medicare payment per Hospitalization with ICD C321 - Malignant neoplasm of supraglottis | $38,047 | ||||
| Total Medicare Charges at DRG | $1,036,941,744 | ||||
| Total Medicare Charges with ICD C321 - Malignant neoplasm of supraglottis | $103,851,760 | ||||
| Avg Charges at DRG | $182,689 | ||||
| Avg Charges with ICD C321 - Malignant neoplasm of supraglottis | $153,627 | ||||
| Mortality Rate at DRG | 2.59 | ||||
| Mortality Rate with ICD C321 - Malignant neoplasm of supraglottis | 1.92 | ||||
| SNF Discharge Rate at DRG | 23.11 | ||||
| SNF Discharge Rate with ICD C321 - Malignant neoplasm of supraglottis | 22.19 | ||||
| Home Discharge Rate at DRG | 14.76 | ||||
| Home Discharge Rate with ICD C321 - Malignant neoplasm of supraglottis | 14.35 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 147: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 004: TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITHOUT MAJOR O.R. PROCEDURE | DRG 129: MAJOR HEAD AND NECK PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) OR MAJOR DEVICE | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 3,132 | ||||
| Total Hospitalizations with ICD C321 - Malignant neoplasm of supraglottis | 217 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD C321 - Malignant neoplasm of supraglottis in DRG | 3.88 | ||||
| Avg LOS at DRG | 5.51 | ||||
| Avg LOS with ICD C321 - Malignant neoplasm of supraglottis | 5.26 | ||||
| Readmission Rate at DRG | 28.63 | ||||
| Readmission Rate with ICD C321 - Malignant neoplasm of supraglottis | 30.37 | ||||
| Unplanned Readmission Rate at DRG | 18.23 | ||||
| Unplanned Readmission Rate with ICD C321 - Malignant neoplasm of supraglottis | 18.32 | ||||
| Total Medicare payments at DRG | $29,387,244 | ||||
| Total Medicare payments with ICD C321 - Malignant neoplasm of supraglottis | $1,968,409 | ||||
| Total Medicare payment per Day at DRG | $1,703 | ||||
| Total Medicare payment per Day with ICD C321 - Malignant neoplasm of supraglottis | $1,725 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,383 | ||||
| Total Medicare payment per Hospitalization with ICD C321 - Malignant neoplasm of supraglottis | $9,071 | ||||
| Total Medicare Charges at DRG | $132,967,234 | ||||
| Total Medicare Charges with ICD C321 - Malignant neoplasm of supraglottis | $9,412,482 | ||||
| Avg Charges at DRG | $42,454 | ||||
| Avg Charges with ICD C321 - Malignant neoplasm of supraglottis | $43,375 | ||||
| Mortality Rate at DRG | 3.99 | ||||
| Mortality Rate with ICD C321 - Malignant neoplasm of supraglottis | NA | ||||
| SNF Discharge Rate at DRG | 13.47 | ||||
| SNF Discharge Rate with ICD C321 - Malignant neoplasm of supraglottis | 12.9 | ||||
| Home Discharge Rate at DRG | 39.59 | ||||
| Home Discharge Rate with ICD C321 - Malignant neoplasm of supraglottis | 40.09 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 130: MAJOR HEAD AND NECK PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 148: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 48,449 | ||||
| Total Hospitalizations with ICD C321 - Malignant neoplasm of supraglottis | 98 | ||||
| DRG Share of Total Hospitalizations | 0.15 | ||||
| % of Total ICD C321 - Malignant neoplasm of supraglottis in DRG | 1.75 | ||||
| Avg LOS at DRG | 29.97 | ||||
| Avg LOS with ICD C321 - Malignant neoplasm of supraglottis | 23.12 | ||||
| Readmission Rate at DRG | 76.3 | ||||
| Readmission Rate with ICD C321 - Malignant neoplasm of supraglottis | 56.98 | ||||
| Unplanned Readmission Rate at DRG | 6.46 | ||||
| Unplanned Readmission Rate with ICD C321 - Malignant neoplasm of supraglottis | 16.28 | ||||
| Total Medicare payments at DRG | $6,190,071,785 | ||||
| Total Medicare payments with ICD C321 - Malignant neoplasm of supraglottis | $9,441,262 | ||||
| Total Medicare payment per Day at DRG | $4,263 | ||||
| Total Medicare payment per Day with ICD C321 - Malignant neoplasm of supraglottis | $4,166 | ||||
| Total Medicare payment per Hospitalization at DRG | $127,765 | ||||
| Total Medicare payment per Hospitalization with ICD C321 - Malignant neoplasm of supraglottis | $96,339 | ||||
| Total Medicare Charges at DRG | $28,754,600,069 | ||||
| Total Medicare Charges with ICD C321 - Malignant neoplasm of supraglottis | $29,022,486 | ||||
| Avg Charges at DRG | $593,502 | ||||
| Avg Charges with ICD C321 - Malignant neoplasm of supraglottis | $296,148 | ||||
| Mortality Rate at DRG | 20.61 | ||||
| Mortality Rate with ICD C321 - Malignant neoplasm of supraglottis | NA | ||||
| SNF Discharge Rate at DRG | 12.46 | ||||
| SNF Discharge Rate with ICD C321 - Malignant neoplasm of supraglottis | 20.41 | ||||
| Home Discharge Rate at DRG | 2.36 | ||||
| Home Discharge Rate with ICD C321 - Malignant neoplasm of supraglottis | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 522,791 | ||||
| Total Hospitalizations with ICD C321 - Malignant neoplasm of supraglottis | 56 | ||||
| DRG Share of Total Hospitalizations | 1.59 | ||||
| % of Total ICD C321 - Malignant neoplasm of supraglottis in DRG | 1.0 | ||||
| Avg LOS at DRG | 3.14 | ||||
| Avg LOS with ICD C321 - Malignant neoplasm of supraglottis | 3.59 | ||||
| Readmission Rate at DRG | 17.1 | ||||
| Readmission Rate with ICD C321 - Malignant neoplasm of supraglottis | 29.09 | ||||
| Unplanned Readmission Rate at DRG | 12.62 | ||||
| Unplanned Readmission Rate with ICD C321 - Malignant neoplasm of supraglottis | 27.27 | ||||
| Total Medicare payments at DRG | $2,290,151,156 | ||||
| Total Medicare payments with ICD C321 - Malignant neoplasm of supraglottis | $285,152 | ||||
| Total Medicare payment per Day at DRG | $1,394 | ||||
| Total Medicare payment per Day with ICD C321 - Malignant neoplasm of supraglottis | $1,419 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,381 | ||||
| Total Medicare payment per Hospitalization with ICD C321 - Malignant neoplasm of supraglottis | $5,092 | ||||
| Total Medicare Charges at DRG | $13,619,287,561 | ||||
| Total Medicare Charges with ICD C321 - Malignant neoplasm of supraglottis | $1,771,020 | ||||
| Avg Charges at DRG | $26,051 | ||||
| Avg Charges with ICD C321 - Malignant neoplasm of supraglottis | $31,625 | ||||
| Mortality Rate at DRG | 0.18 | ||||
| Mortality Rate with ICD C321 - Malignant neoplasm of supraglottis | NA | ||||
| SNF Discharge Rate at DRG | 8.57 | ||||
| SNF Discharge Rate with ICD C321 - Malignant neoplasm of supraglottis | NA | ||||
| Home Discharge Rate at DRG | 72.49 | ||||
| Home Discharge Rate with ICD C321 - Malignant neoplasm of supraglottis | 55.36 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| THE UNIVERSITY OF CHICAGO MEDICAL CENTER | 5841 S. MARYLAND AVE | CHICAGO | IL | 60637 | 80 |
| BARNES JEWISH HOSPITAL | 1 BARNES-JEWISH HOSPITAL PLZ | SAINT LOUIS | MO | 63110 | 58 |
| ARTHUR G JAMES CANCER HOSPITAL | 300 W 10TH AVE | COLUMBUS | OH | 43210 | 56 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. DANIEL J HARAF | 5841 S MARYLAND AVE # MC1099 | CHICAGO | IL | 60637 | 15 |
| Dr. ISSAM N. EID | 2500 N STATE ST | JACKSON | MS | 39216 | 15 |
| Dr. CLARENCE T SASAKI | 800 HOWARD AVE | NEW HAVEN | CT | 06519 | 15 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. ISSAM N. EID | 2500 N STATE ST | JACKSON | MS | 39216 | 17 |
| Dr. CLARENCE T SASAKI | 800 HOWARD AVE | NEW HAVEN | CT | 06519 | 15 |
| Dr. EMRE VURAL | 4301 W MARKHAM ST # 783 | LITTLE ROCK | AR | 72205 | 13 |